Overview
Status
Active
Registry date
2015-08-10
Share capital
5 000,00 PLN
Registered address
ul. Rybitwy 4/12, 02-806 Warszawa, Poland
Industry
Bank accounts
Registered as a VAT taxpayer on 2015-09-14. Active
93 1090 1870 0000 0001 3108 6083
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Tomasz Giller — Attorney-in-fact (sole)
Paweł Jan Woźniak — President of the Management Board
Manner of representation
In the case of a one-person management board, the company is represented independently by a member of the management board, whereas in the case of a multi-member management board, the company is represented by two members of the management board acting jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Paweł Jan Woźniak (46) | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Paweł Jan Woźniak (46) | Shareholder of a limited liability company, 5000.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Grupa FinepharmS.A. | — | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-09-17 | Address change (Ul. Ogrodowa 31/35, 00-893, Warszawa → Ul. Rybitwy 4/12, 02-806, Warszawa) | |
| 2019-08-01 | Business resumed | |
| 2017-07-31 | Business suspended | |
| 2016-02-19 | Address change (Ul. Rybitwy 4/12, 02-806, Warszawa → Ul. Ogrodowa 31/35, 00-893, Warszawa) | |
| 2015-08-10 | Entered in the register |
FAQ
The main business activity of Sigma Therapeutics focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on August 10, 2015.
The headquarters is located at: ul. Rybitwy 4, 02-806 Warszawa.
The management board includes Paweł Jan Woźniak (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-04-13